Home ›Top Stories ›Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources
MASIGNASUKAv102
6510051498749449419

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources
The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources. 

from IndiaTV: Google News Feed https://ift.tt/3d3dcR1
Ankkit

Related Post

comment 0 Comments

more_vert

:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
-_-
(o)
[-(
:-?
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
$-)
(y)
(f)
x-)
(k)
(h)
(c)
cheer
(li)
(pl)
Emoticon Feedback